Home > PE Ratio > WOCKHARDT

WOCKHARDT
PE (Price/Earnings) Ratio

The Current P/E Ratio of WOCKHARDT is -505.29.

Share Price ₹1,772.4Jul 18,2025
Market Cap ₹28,801.5 Cr
Earnings-TTM₹-57.0 CrTTM-Consolidated Results
Price/Earnings-505.29xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for WOCKHARDT
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of WOCKHARDT

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of WOCKHARDT is calculated as :

Current Market Cap [ ₹28,801.5 Cr] as on Jul 18,2025

(/) Earnings [ ₹-57.0 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ -505.29x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for WOCKHARDT , the investors are currently willing to pay -505.29 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of WOCKHARDT !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of WOCKHARDT over the last five years.

Historical PE (Price/Earnings) ratio chart of WOCKHARDT


PE Ratio Performance Analysis for WOCKHARDT

- WOCKHARDT 's latest p/e ratio is -505.29x.

- WOCKHARDT 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.22x.

- WOCKHARDT 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, WOCKHARDT 's p/e ratio peaked in Mar2021 at 6.12x.

- WOCKHARDT 's p/e ratio hit its five-year low in Mar2025 of 0x.


How does WOCKHARDT 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
WOCKHARDT -57.00-505.2928,801.5
SUN PHARMACEUTICAL INDUSTRIES LTD10,980.1037.00406,267.0
DIVIS LABORATORIES LTD2,191.0081.55178,672.0
CIPLA LTD5,291.0522.63119,713.0
TORRENT PHARMACEUTICALS LTD1,911.0062.37119,195.0
DR REDDYS LABORATORIES LTD5,703.5018.41104,999.0
MANKIND PHARMA LTD2,003.2254.66109,495.0
ZYDUS LIFESCIENCES LTD4,614.8021.2698,133.0
LUPIN LTD3,306.2626.6788,191.1
AUROBINDO PHARMA LTD3,515.2618.8266,167.8
ABBOTT INDIA LTD1,414.4451.3072,563.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs WOCKHARDT 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -505.29x
Max industry PE 81.55x
Median industry PE 26.67x
Average industry PE -10.06x



You may also like the below Video Courses